Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Health Catalyst (HCAT) Revenue (2018 - 2025)

Health Catalyst (HCAT) has disclosed Revenue for 8 consecutive years, with $76.3 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Revenue changed 0.04% year-over-year to $76.3 million, compared with a TTM value of $316.1 million through Sep 2025, up 4.64%, and an annual FY2024 reading of $306.6 million, up 3.6% over the prior year.
  • Revenue was $76.3 million for Q3 2025 at Health Catalyst, down from $80.7 million in the prior quarter.
  • Across five years, Revenue topped out at $80.7 million in Q2 2025 and bottomed at $55.8 million in Q1 2021.
  • Average Revenue over 5 years is $71.4 million, with a median of $73.8 million recorded in 2023.
  • The sharpest move saw Revenue surged 37.84% in 2021, then fell 0.04% in 2025.
  • Year by year, Revenue stood at $64.7 million in 2021, then grew by 6.87% to $69.2 million in 2022, then grew by 8.56% to $75.1 million in 2023, then rose by 6.02% to $79.6 million in 2024, then decreased by 4.12% to $76.3 million in 2025.
  • Business Quant data shows Revenue for HCAT at $76.3 million in Q3 2025, $80.7 million in Q2 2025, and $79.4 million in Q1 2025.